Boon Cher Goh Selected Research

Biomarkers (Surrogate Marker)

1/2022	Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA.
1/2022	Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer.
1/2021	Extracellular vesicles, the cornerstone of next-generation cancer diagnosis?
4/2016	(68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
1/2016	Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy.
3/2015	Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.
9/2014	DEAD-box helicase DP103 defines metastatic potential of human breast cancers.
11/2011	A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boon Cher Goh Research Topics

Disease

63	Neoplasms (Cancer) 09/2022 - 03/2003
13	Nasopharyngeal Carcinoma 11/2022 - 04/2004
13	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2004
11	Breast Neoplasms (Breast Cancer) 02/2022 - 05/2014
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2008
6	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 07/2008
5	Carcinogenesis 01/2021 - 01/2018
4	Neutropenia 02/2022 - 09/2007
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2007
4	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 10/2010
4	Carcinoma (Carcinomatosis) 01/2020 - 01/2004
3	Disease Progression 09/2021 - 10/2010
3	Body Weight (Weight, Body) 03/2015 - 07/2005
2	Triple Negative Breast Neoplasms 01/2022 - 09/2021
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Hypertension (High Blood Pressure) 10/2020 - 09/2012
2	Stomach Neoplasms (Stomach Cancer) 06/2019 - 01/2016
2	Squamous Cell Carcinoma of Head and Neck 12/2016 - 03/2015
2	Anaplastic Thyroid Carcinoma 09/2012 - 10/2010
1	Exanthema (Rash) 09/2022
1	Ovarian Neoplasms (Ovarian Cancer) 02/2022
1	Ovarian Epithelial Carcinoma 02/2022
1	Fallopian Tube Neoplasms 02/2022
1	Febrile Neutropenia 01/2022
1	COVID-19 05/2021

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 02/2022 - 10/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
7	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 04/2004
6	Bevacizumab (Avastin)FDA Link 02/2022 - 07/2008
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2008
6	Phosphotransferases (Kinase)IBA 01/2021 - 10/2010
5	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2004
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 06/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2007
4	Carboplatin (JM8)FDA LinkGeneric 02/2022 - 03/2015
4	Sunitinib (Sutent)FDA Link 02/2022 - 10/2020
4	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 12/2016
4	Tyrosine Kinase InhibitorsIBA 08/2021 - 09/2009
4	pazopanib FDA Link 01/2020 - 09/2009
4	Irinotecan (Camptosar)FDA LinkGeneric 09/2007 - 01/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 07/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 11/2020
3	Hormones (Hormone)IBA 01/2022 - 09/2016
3	Angiogenesis InhibitorsIBA 01/2022 - 11/2011
3	Oncogene Proteins (Oncogene Protein)IBA 11/2021 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2015
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2020 - 04/2015
3	Gemcitabine FDA Link 10/2020 - 04/2008
2	Biological ProductsIBA 01/2022 - 03/2020
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2020
2	PanobinostatIBA 09/2021 - 01/2018
2	Histone Deacetylase InhibitorsIBA 09/2021 - 01/2018
2	PPAR gammaIBA 09/2021 - 05/2014
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2021 - 01/2018
2	Thyroglobulin FDA Link 01/2021 - 01/2020
2	IodineIBA 01/2021 - 01/2020
2	EnzymesIBA 01/2021 - 07/2016
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 01/2016
2	AntigensIBA 01/2019 - 01/2016
2	Gefitinib (Iressa)FDA Link 01/2018 - 01/2007
2	CarcinogensIBA 01/2018 - 07/2016
2	Terpenes (Terpenoids)IBA 12/2016 - 04/2015
2	ascochlorinIBA 12/2016 - 04/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2016 - 04/2015
2	AntioxidantsIBA 09/2016 - 06/2015
2	nimbolideIBA 07/2016 - 04/2016
2	Superoxide DismutaseIBA 01/2016 - 05/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015 - 07/2015
2	garcinolIBA 06/2015 - 03/2015
1	Chimeric Antigen ReceptorsIBA 11/2022
1	Cetuximab (Erbitux)FDA Link 09/2022
1	VaccinesIBA 06/2022
1	NucleotidesIBA 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	lenvatinibIBA 01/2022
1	ElectrolytesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Pizotyline (BC 105)IBA 12/2021
1	Rosiglitazone (Avandia)FDA Link 09/2021
1	Antineoplastic Agents (Antineoplastics)IBA 09/2021
1	celastrolIBA 09/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 08/2021
1	Proton Pump InhibitorsIBA 08/2021
1	Povidone-Iodine (Betadine)FDA LinkGeneric 05/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2021
1	pembrolizumabIBA 01/2021

Therapy/Procedure

31	Therapeutics 09/2022 - 01/2012
17	Drug Therapy (Chemotherapy) 02/2022 - 04/2004
5	Immunotherapy 01/2022 - 01/2016
5	Radiotherapy 12/2016 - 04/2004
3	Brachytherapy 06/2006 - 04/2004
2	Drug Tapering 09/2012 - 10/2010
1	Secondary Prevention 01/2022
1	Neoadjuvant Therapy 01/2022
1	Heterologous Transplantation (Xenotransplantation) 12/2021
1	Chemoprevention 05/2021